Search
Ionis Pharmaceuticals Inc
IONSAdd to Watchlist
45.280USD
+1.980+4.57%
Close 10-09 16:00（ET）
7.52BMarket Cap
LossP/E TTM
Ionis Pharmaceuticals Inc (IONS) Stock Price Target & Forecast
Analyst Rating
Based on 25 analysts giving stock ratings to Ionis Pharmaceuticals Inc in the past month.
Buy
6 Strong Buy
14 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
84.378USD+91.07%
IONS Analyst Recommendation Trends
In the current month, IONS has received 14 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. IONS average Analyst price target in the last month is 84.378.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
6
6
9
8
7
7
7
7
14
14
13
14
13
10
10
10
5
5
5
5
5
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25
25
27
27
25
23
23
23
IONS Analyst Rating for Peer Comparison
Updated: Oct 10, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, IONS EPS is projected to reach -1.201 in FY2026Q3, following reported EPS of -0.693 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.32
-0.91
-1.07
-1.20
-1.13
Actual
-1.41
-0.56
-0.69
--
--
Surprise
-6.92%
+38.34%
+35.10%
--
--
FAQs
What is Ionis Pharmaceuticals Inc's expected revenue for the next quarter?
Ionis Pharmaceuticals Inc's expected revenue is 183.01M.
What is Ionis Pharmaceuticals Inc's price target?
Analysts forecast that Ionis Pharmaceuticals Inc's price target is USD 84.38, with the highest forecast at USD 105.00 and the lowest forecast at USD 54.00.
How have Ionis Pharmaceuticals IncIONS's recent earnings per share performed?
The market expectation was USD -0.69, while Ionis Pharmaceuticals IncIONS's earnings per share (EPS) for the previous quarter was USD -0.56. EPS for the next quarter is expected at USD -1.20.
What is the analyst rating for Ionis Pharmaceuticals Inc?
Based on the ratings of Ionis Pharmaceuticals Inc's stock from 25 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.